未登录

N

Nathalie Gosselin

certara

H指数:32

被引数:4,420

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Population Pharmacokinetics and Exposure-Response Analysis of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 Mutation

Ziftomenib在NPM1突变复发或难治性急性髓系白血病患者中的群体药代动力学和暴露-反应分析

cpt: pharmacometrics & systems pharmacology

IF0

2026-05-040

OAAI

Population Pharmacodynamic Modeling of Plozasiran for Treatment of Familial Chylomicronemia Syndrome

Plozasiran治疗家族性乳糜微粒血症的群体药效动力学模型

Journal of Clinical Pharmacology

IF2.3

2026-04-190

PRE

How Familiarity, Musical Affinity, and ADHD Shape Adolescents’ Perception of Musical Emotions

熟悉度、音乐亲和力及ADHD如何塑造青少年对音乐情感的认知

Behavioral Sciences 2025, Vol. 15, Page 1570

IF2.5

2025-11-180

OAAI

An immersive ecological measure of noise-induced functional interference in adults with hyperacusis

成人中噪声诱发的功能性干扰的沉浸式生态测量

Hearing Research

IF2.5

2025-10-280

OAAI

Population Pharmacokinetics and Exposure-Response of Subcutaneous Atezolizumab in Patients With Non-Small Cell Lung Cancer

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY

IF3

2025-02-050

OA

Listening habits and subjective effects of background music in young adults with and without ADHD

背景音乐在有无ADHD的青年人群中的聆听习惯与主观效应

FRONTIERS IN PSYCHOLOGY

IF2.9

2025-01-220

OA

Model-Informed Approach to Recommend Burosumab Dosing Regimens for Pediatric and Adult Patients With the Ultrarare Disease Tumor-Induced Osteomalacia

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2024-10-240

PRE

Estimating potential cardiovascular health benefits of improved population level control of LDL cholesterol through a twice-yearly siRNA-based approach: A simulation study of a health-system level intervention

ATHEROSCLEROSIS

IF5.7

2024-04-013

OAAI

Translational Population-Pharmacodynamic Modeling of a Novel Long-Acting siRNA Therapy, Inclisiran, for the Treatment of Hypercholesterolemia

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2022-11-146

PRE

Pitch and Rhythm Perception and Verbal Short-Term Memory in Acute Traumatic Brain Injury

behavioral and brain sciences

IF2.8

2021-09-034

OAAI

Population Pharmacokinetic-Pharmacodynamic Model of Serum Transthyretin Following Patisiran Administration

NUCLEIC ACID THERAPEUTICS

IF4.7

2020-06-0120

OAAI

Neuropsychology supervision: A survey of practices in Quebec and a cross-cultural comparison

神经心理学监督: 魁北克实践调查和跨文化比较

CLINICAL NEUROPSYCHOLOGIST

IF2.7

2020-03-032

PREAI

A randomized, double-blind, placebo-controlled, pharmacokinetic and pharmacodynamic study of a fixed-dose combination of phentermine/topiramate in adolescents with obesity

DIABETES OBESITY & METABOLISM

IF5.7

2019-12-1827

PREAI

Exposure-Response Relationship of Obeticholic Acid for Alkaline Phosphatase and Total Bilirubin in Patients With Primary Biliary Cirrhosis (PBC)

GASTROENTEROLOGY

IF25.1

2016-04-010

PREAI

Bevacizumab dosing strategy in paediatric cancer patients based on population pharmacokinetic analysis with external validation

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2015-12-1032

OAAI

Sensitivity to musical emotions in congenital amusia

IF3.3

2015-10-0157

PREAI

Pharmacokinetic and Pharmacodynamic Modeling To Determine the Dose of ST-246 To Protect against Smallpox in Humans

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2013-03-0123

OAAI

Relationship between prenatal exposure to polychlorinated biphenyls and birth weight: A systematic analysis of published epidemiological studies through a standardization of biomonitoring data

REGULATORY TOXICOLOGY AND PHARMACOLOGY

IF3.5

2012-10-0124

PREAI

Priming paradigm reveals harmonic structure processing in congenital amusia

IF3.3

2012-09-0150

PRE

Statistical learning of speech, not music, in congenital amusia

NEUROSCIENCES AND MUSIC IV: LEARNING AND MEMORY

IF0

2012-04-2332

OA